Arrowstreet Capital’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-80,230
Closed -$10.3M 1704
2021
Q3
$10.3M Buy
80,230
+68,095
+561% +$9.53M 0.01% 730
2021
Q2
$1.85M Buy
+12,135
New +$1.6M ﹤0.01% 1376
2020
Q3
Sell
-74,741
Closed -$4.6M 2505
2020
Q2
$4.6M Buy
+74,741
New +$3.05M 0.01% 1094
2018
Q4
Sell
-44,325
Closed -$2.13M 1501
2018
Q3
$2.13M Sell
44,325
-59,605
-57% -$2.44M ﹤0.01% 676
2018
Q2
$3.22M Buy
+103,930
New +$2.43M 0.01% 613
2014
Q2
Sell
-25,070
Closed -$471K 1163
2014
Q1
$471K Buy
+25,070
New +$404K ﹤0.01% 970
2013
Q3
Sell
-26,952
Closed -$274K 1116
2013
Q2
$274K Buy
+26,952
New +$218K ﹤0.01% 694

Other funds holding STAA

Arrowstreet Capital's STAA Position: Q4 2021 in Review

Arrowstreet Capital sold out of STAAR Surgical (STAA) in Q4 2021, closing a stake of 80,230 shares — an estimated $10.3M sold.

Arrowstreet Capital first reported a position in STAA in Q2 2013 and held it in 7 quarters. The position peaked at $10.3M in Q3 2021. 279 funds tracked by Wall St. Rank hold STAA as of Q4 2021.

  • Arrowstreet Capital reported no remaining STAAR Surgical position as of Q4 2021 after selling out during the quarter.
  • Arrowstreet Capital sold 80,230 STAAR Surgical shares in Q4 2021, an estimated $10.3M.
  • Arrowstreet Capital first reported a position in STAAR Surgical in Q2 2013 and held it in 7 quarters.
  • Arrowstreet Capital's STAAR Surgical position peaked at $10.3M in Q3 2021.
  • 279 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2021.

Based on Arrowstreet Capital's 13F filing for Q4 2021, filed 14 Feb 2022.